Elevated calcitonin precursor levels are related to mortality in an animal model of sepsis

Critical Care

Volumn 3, Issue 1, 1999, Pages 11-16

  Steinwald, Paul M ^a   Whang, Kevin T ^b   Becker, Kenneth L ^a   Snider, Richard H ^a   Nylen, Eric S ^a   White, Jon C ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Inflammation; Peritonitis; Procalcitonin; Prohormone; Serum marker

Indexed keywords

CALCITONIN; PROCALCITONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL PERITONITIS; CALCITONIN BLOOD LEVEL; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; ESCHERICHIA COLI; HYPOCALCEMIA; IMMUNOREACTIVITY; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; SEPSIS; SYRIAN HAMSTER;

EID: 0033042269     PISSN: 13648535     EISSN: None     Source Type: Journal    
DOI: 10.1186/cc300     Document Type: Article

References (36)

1. American College of Chest Physicians - Society of Critical Care Consensus Conference: Definitions of sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992, 20:864-874.
2. Parillo JE (moderator): Septic shock in humans: advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 1990, 113:227-242.
3. Bone RC, Fisher CJ, Clemmer TP, et al: Sepsis syndrome: a valid clinical entity. Crit Care Med 1989, 17:389-393.
4. Christman JW, Holden EP, Blackwell TS: Strategies for blocking the systemic effects of cytokines in the sepsis syndrome. Crit Care Med 1995, 25:955-963.
5. Zeigler EJ, Fisher CJ, Spriung CL, et al: Treatment of gram-negative bacteremia and septic shock with HA-IA human monoclonal antibody against endotoxin. N Engl J Med 1991, 324:429-436.
6. Lowry SF: Sepsis and it complications: clinical definitions and therapeutic prospects. Crit Care Med 1994, 22:51-52.
7. Bone RC: Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome. What we know and what we do not know about cytokine regulation. Crit Care Med 1996, 24:163-172.
8. Rutledge R, Fakhry S, Rutherford E, Muakkassa F, Meyer A: Comparison of APACHE II, Trauma Score and Injury Severity Score as predictors of outcome in critically injured patients. Am J Surg 1993, 166:244-247.
9. Cerra FB, Negro F, Abrams J: APACHE II score does not predict multiple organ failure or mortality in postoperative surgical patients. Arch Surg 1990, 125:519-522.
10. Meyer AA, Messick J, Young P, et al: Prospective comparison of clinical judgment and APACHE II score in predicting the outcome in critically ill surgical patients. J Trauma 1992, 32:747-753.
11. Nylen E, O'Neill W, Jordan M, et al: Serum procalcitonin as an index of inhalation injury in burns. Horm Metab Res 1992, 24:439-443.
12. Assicot M, Gendrel D, Carsin H, et al: High serum calcitonin concentrations in patients with sepsis and infection. Lancet 1993, 341:515-518.
13. Whang KT, Steinwald PM, White JC, et al: Serum calcitonin percursors in sepsis and systemic inflammation. J Clin Endocrinol Metab 1998, 83:3296-3301.
14. Stevenson JC, Hillyard CJ, MacIntyre I, Cooper H, Whitehead MI: A physiologic role for calcitonin: protection of the maternal skeleton. Lancet 1979, ii:769-770.
15. Nylen ES, Linnoila I, Snider RH, Tabassian AR, Becker KL: Comparative studies of hamster calcitonin from pulmonary endocrine cells in vitro. Peptides 1987, 8:977-982.
16. Becker KL, Nylen ES, Cohen R, Snider RH: Calcitonin: structure, molecular biology, and actions. In: Bilezikian J, Raisz LG, Rodan GA (editors). Principles of Bone Biology. San Diego, California: Academic Press, 1996. pp. 471-493.
17. Snider RH, Nylen ES, Becker KL: Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization. J Invest Med 1997, 45:552-560.
18. Dunne JR, Dunkin BJ, Nelson S, White JC: Effects of granulocyte colony stimulation factor in a non-neutropenic rodent model of Escherichia coli peritonitis. J Surg Res 1996, 61:348-354.
19. Snider RH, Moore CF, Silva OL, Becker KL: Radioimmunoassay of calcitonin in normal human urine. Anal Chem 1978, 50:449-454.
20. Snider RH, Silva OL, Moore CF, Becker KL: Immunochemical heterogeneity of calcitonin in man: effect on radioimmunoassay. Clin Chim Acta 1977, 76:1-14.
21. Nylen ES, Arifi A, Becker KL, Snider RH, Alzeer A: The effect of classical heat stroke on serum procalcitonin. Crit Care Med 1997, 25:1362-1365.
22. Davis TME, Assicot M, Bohuon C, et al: Serum procalcitonin concentrations in acute malaria. Trans Roy Soc Trop Med Hyg 1994, 88:670-671.
23. rd Annual Meeting of the American Burn Association. April 1991, Baltimore, MD [abstract 194].
24. Becker KL, Snider RH, Moore CF, et al: Calcitonin in extrathyroidal tissues in man. Acta Endocrinol (Copenhagen) 1979, 92:746-751.
25. Zaidi M, Bax BE, Shankar VS, et al: Dimensional analysis of osteoclastic bone resorption and the measurement of biologically active calcitonin. Exp Physiol 1994, 79:387-399.
26. Rothman JE, Orci L: Movement of proteins through the Golgi stack: a molecular dissection of vesicular transport. FASEB J 1990, 4: 1460-1468.
27. Treilhou-Lahille F, Pidoux E, Day F, et al: Granular and extragranular forms of immunoreactive calcitonin in normal rat 'C' cells. Biology of the Cell 1986, 57:221-230.
28. Burgess TL, Kelly RB: Constitutive and regulated secretion of proteins. Ann Rev Cell Biol 1987, 3:243-293.
29. Bershadsky AD, Futerman AH: Disruption of the Golgi apparatus by brefeldin A blocks polarization and inhibits directed cell migration. Proc Natl Acad Sci 1994, 91:5686-5689.
30. Todd JC, Mollitt DL: Sepsis-induced alterations in the erythrocyte membrane. Am Surg 1994, 60:954-957.
31. Madara JL, Stafford J: Interferon-γ directly affects barrier function of cultured intestinal epithelial monolayers. J Clin Invest 1989, 83: 724-727.
32. Chernow B, Zaloga G, McFadden E, et al: Hypocalcemia in critically ill patients. Crit Care Med 1982, 10:848-851.
33. Desai TK, Carlson RW, Geheb MA: Prevalence and clinical implications of hypocalcemia in acutely ill patients in a medical intensive care setting. Am J Med 1988, 84:209-214.
34. Dandona P, Nix D, Wilson MF, et al: Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994, 79:1605-1608.
35. Becker KL, Whang KT, Snider RH, et al: Relation between cytokines and procalcitonin peptides in an animal model of infection. Ann Endocrinol 1998, 59:170.
36. Nylen ES, Whang KT, Snider RH, Steinwald PM, White JC, Becker KL: Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med 1998, 26:1001-1006.